1-4 of 4
Nai-Kong V. Cheung, MD, PhD
Close
Sort by
Journal Articles

PD-L1 Checkpoint Blockade Augments Anti-Tumor Immune Response of GD2 or HER2-Bsab Ex Vivo Armed T-Cells (EVAT) Therapy in Osteosarcoma

Jeong A Park, MD PhD, Hong fen Guo, PhD, Hong Xu, PhD, Nai-Kong V. Cheung, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 1959.
https://doi.org/10.1182/blood-2019-131325
Published: 2019
Journal Articles

Exceptionally Potent Cytotherapy Using T Cells Armed with Novel Tetravalent Recombinant Bispecific Antibodies Specific for GD2 and HER2

Jeong A Park, MD PhD, Hong Xu, PhD, Brian Santich, PhD, Nai-Kong V. Cheung, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 4536.
https://doi.org/10.1182/blood-2018-99-120210
Published: 2018
Journal Articles

Early Detection and Molecular Characterization of Therapy-Related Leukemia in Children Reveals Patterns of Disease Transformation and Guides Future Surveillance Protocols

Barbara Spitzer, MD, Gunes Gundem, PhD, Noushin Farnoud, PhD, Nathan Millard, MD, Erin McGovern, BA, Minal Patel, BA, Max Levine, MS, Juan Medina, MS, Yangyu Zhou, BS, Juan E. Arango Ossa, BS, Michael Francis Walsh, MD, Ross L. Levine, MD, Irene Y. Cheung, ScD, Scott A. Armstrong, MD PhD, Nai-Kong V. Cheung, MD PhD, Elli Papaemmanuil, PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 291.
https://doi.org/10.1182/blood-2018-99-120005
Published: 2018
Journal Articles

Bone Marrow Replacement with a Clone Harboring Novel t(4;11)(p12;q23) Involving MLL during Neuroblastoma Treatment Is Not Associated with Leukemia.

Blaine W. Robinson, PhD, Andrew Lee, Nai-Kong V. Cheung, MD, PhD, Carolyn A. Felix, MD
Journal: Blood
Blood (2004) 104 (11): 2903.
https://doi.org/10.1182/blood.V104.11.2903.2903
Published: 2004